LENZ Therapeutics LENZ
NASDAQ LENZ
$4.11 +0.01 (+0.24%)
At close: Nov 11, 2026 · 4:00 PM EST

LENZ Therapeutics (LENZ) Change in Accrued Expenses (2020 - 2026)

Updated

LENZ Therapeutics' Change in Accrued Expenses came in at -$5.11 million for Q2 2026, compared with $2.69 million a year earlier.

Analysis

LENZ Therapeutics (LENZ) Change in Accrued Expenses (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, LENZ Therapeutics reported Change in Accrued Expenses of $2.26 million, down 35.4% year-over-year; for FY2025, it was $10.98 million.

  • Change in Accrued Expenses carries a five-year compound annual growth rate of 88.1% (FY2020 to FY2025).
  • Going back by year, Change in Accrued Expenses was -$7.46 million in FY2024, $7.78 million in FY2023 (+601.2%), $1.11 million in FY2022 (-50.1%) and $2.22 million in FY2021 (+377.0%).
  • The Q2 2026 figure represents the lowest quarterly Change in Accrued Expenses since Q1 2024.
  • Year-over-year, Change in Accrued Expenses increased in two of the last four quarters, with growth averaging 177.0%.
  • The fastest year-over-year change in Change in Accrued Expenses over five years came in Q3 2021 (growth of 700.0%), and the weakest in Q3 2024 (a decline of 78.4%).
  • Business Quant data shows LENZ's Change in Accrued Expenses at -$2.11 million (Q1 2026), $5.03 million (Q4 2025) and $4.46 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accrued Exp. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.41 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 983.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -87.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 756.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 LENZ Therapeutics 128.82 Mn -839.21 Mn 2.93 Mn 2.45 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 2.45 Mn
Jun 30, 2026 -5.11 Mn
Mar 31, 2026 -2.11 Mn
Dec 31, 2025 5.03 Mn
Sep 30, 2025 4.46 Mn
Jun 30, 2025 2.69 Mn
Mar 31, 2025 -1.20 Mn
Dec 31, 2024 1.30 Mn
Sep 30, 2024 721,000.00
Jun 30, 2024 -2.25 Mn
Mar 31, 2024 -7.23 Mn
Dec 31, 2023 1.62 Mn
Sep 30, 2023 3.34 Mn
Jun 30, 2023 2.98 Mn
Mar 31, 2023 -148,000.00
Dec 31, 2022 453,000.00
Sep 30, 2022 1.17 Mn
Jun 30, 2022 1.16 Mn
Mar 31, 2022 -1.67 Mn
Dec 31, 2021 1.03 Mn
API Access

LENZ Therapeutics Change in Accrued Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=LENZ&period=max&api_key=YOUR_API_KEY